TY  - GEN
AU  - Smyth-Medina,Robert
AU  - Johnston,Josh
AU  - Devries,Douglas K
AU  - Jasper,April
AU  - Kannarr,Shane R
AU  - Schechter,Barry A
AU  - Shen Lee,Bridgitte
AU  - Varghese,George
AU  - Ogundele,Abayomi
AU  - Darby,Charles H
AU  - Karpecki,Paul
AU  - Luchs,Jodi
TI  - Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials
SN  - 1557-7732
PY  - 2020///0617
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Cyclosporine
KW  - administration & dosage
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Keratoconjunctivitis Sicca
KW  - drug therapy
KW  - Micelles
KW  - Nanoparticles
KW  - Randomized Controlled Trials as Topic
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1089/jop.2018.0154
ER  -